P L Sheridan - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serumN J DePolo, J D Reed, P L Sheridan, et al.

Genes & Development|September 1, 1995

Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitroP L Sheridan, C T Sheline, K Cannon, et al.

Biochemistry|September 22, 1987

Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processingL L Wei, P L Sheridan, N L Krett, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serumN J DePolo, J D Reed, P L Sheridan, et al.

Genes & Development|September 1, 1995

Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitroP L Sheridan, C T Sheline, K Cannon, et al.

Biochemistry|September 22, 1987

Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processingL L Wei, P L Sheridan, N L Krett, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.

Pageof 2